SEC Company Response from AIM ImmunoTech Inc. (AIM) (CIK 0000946644) (AIM) — Sep 24, 2019
AIM ImmunoTech Inc. (AIM) (CIK 0000946644)
Date: Sept. 24, 2019 · CIK: 0000946644 · Accession: 0001493152-19-014475
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-233657
Letter
Re: AIM ImmunoTech Inc.
September 23, 2019
VIA EDGAR
Securities and Exchange Commission
F Street, NE
Washington, DC 20549
Registration Statement on Form S-1
(SEC filing No. 333-233657)
Acceleration Request
Requested Date: September 24, 2019
Requested Time: 5:30 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), AIM ImmunoTech Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-1 (File No. 333-233657) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission (the Commission”).
The Company understands that the Commission will consider this request for acceleration of the effective date of the Registration Statement as a confirmation of the fact that the Company is aware of its responsibilities under the Securities Act and the Securities Exchange Act of 1934, as amended, as they relate to the proposed public offering of the securities specified in the Registration Statement.
Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Silverman Shin & Byrne PLLC, by calling Richard Feiner, Esq. at (646) 822-1170. We also respectfully request that a copy of the written order from the Commission verifying the effective date and time of the Registration Statement be sent to Mr. Feiner via email at rfeiner@silverfirm.com.
Very
truly yours,
AIM
ImmunoTech Inc.
Show Raw Text
CORRESP
1
filename1.htm
September
23, 2019
VIA
EDGAR
Securities
and Exchange Commission
100
F Street, NE
Washington,
DC 20549
Re:
AIM
ImmunoTech Inc.
Registration
Statement on Form S-1
(SEC
filing No. 333-233657)
Acceleration
Request
Requested
Date: September 24, 2019
Requested
Time: 5:30 P.M. Eastern Time
Ladies
and Gentlemen:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), AIM ImmunoTech Inc. (the “Company”)
hereby requests that the above-referenced Registration Statement on Form S-1 (File No. 333-233657) (the “Registration Statement”)
be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time
as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the
Securities and Exchange Commission (the Commission”).
The
Company understands that the Commission will consider this request for acceleration of the effective date of the Registration
Statement as a confirmation of the fact that the Company is aware of its responsibilities under the Securities Act and the Securities
Exchange Act of 1934, as amended, as they relate to the proposed public offering of the securities specified in the Registration
Statement.
Once
the Registration Statement has been declared effective, please orally confirm that event with our counsel, Silverman Shin &
Byrne PLLC, by calling Richard Feiner, Esq. at (646) 822-1170. We also respectfully request
that a copy of the written order from the Commission verifying the effective date and time of the Registration Statement be sent
to Mr. Feiner via email at rfeiner@silverfirm.com.
Very
truly yours,
AIM
ImmunoTech Inc.
By:
/s/
Ellen Lintal
Ellen
Lintal,
Chief
Financial Officer
cc:
Richard Feiner, Esq.
Corporate
Headquarters
2117
SW Highway 484, Ocala FL 34473
t:
352-448-7797
f:
352-480-4620
Finance
& Administration
604
Main Street, Riverton NJ 08077
t:
352-448-7797
f:
352-480-4620
Manufacturing
783
Jersey Ave, New Brunswick, NJ 08901
www.aimimmuno.com
t:
732-249-3250
f: 732-249-6895